Indegene ties up with Microsoft to leverage generative AI for the Medical Industry

“GenAI presents a once-in-a-decade opportunity for life sciences companies to modernize business processes and reimagine the effectiveness and efficiency of their operations throughout the value chain. Using GenAI, we’re closely working with many of our clients to solve specific business problems, with nearly 50 real-world use cases already in an advanced pilot stage”, said Tarun Mathur, CTO, of Indegene.